Phase 1 Single Subcutaneous Dose Study of MLN1202

Clinical trial NCT02426021 · WITHDRAWN

Trial details

NCT number: NCT02426021
Sponsor: Takeda
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Japanese and Caucasian Male Adults

Start date: 2015-04-01
Primary completion: 2015-11-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.